The majority of high grade serous endometrial and ovarian cancers harbor mutated TP53. These are aggressive, often lethal tumors that are an important cause of the significantly rising morbidity and mortality from endometrial cancer and are associated with ovarian cancer recurrence. Here, TP53 is linked to endometrial cancer.